Skip to main content

Table 6 Description of antecedent statin use, if continued during admission and reason for discontinuation

From: Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching

Characteristic Total cohort
Home statins documented 438 (47.5)
Continued inpatient statins 217 (49.5)
New inpatient statins 33 (13.2)
Reason for discontinued home statins
 Rhabdomyolysis 20 (9.2)
 Transaminitis 33 (15.2)
 Cannot tolerate oral medications 26 (12)
 Admission < 48 h 18 (8.3)
 Myalgias 3 (1.4)
 Cannot be determined 117 (53.9)
Reason for new inpatient statins
 NSTEMI 12 (36.4)
 Acute stroke 4 (12.1)
 New Heart Failure 1 (3)
 New diabetes 3 (9.1)
 Cannot be determined 13 (39.4)